NUtrition and ORal Health in Orthopaedic Surgery
Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Mar 18, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Nutrition and Oral Health in Orthopaedic Surgery," is studying how a patient's oral health and diet can affect their recovery after major orthopedic surgery, such as hip, knee, or spine surgery. Researchers are looking at the dental health of 64 adult patients and comparing it to what the patients eat, to understand if there’s a link between the two.
To participate in this study, you need to be at least 55 years old and scheduled for a major elective orthopedic surgery. Both men and women can take part, as long as they can follow the study guidelines and do not have certain medical conditions, like serious mental health issues. If you join the study, you will help researchers learn more about the importance of nutrition and oral health for better recovery outcomes in orthopedic surgery. Your involvement could contribute to important findings that may benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥55
- • Male and female gender
- • Major elective orthopedic surgery (hip, knee, spinal)
- • Signature of the informed consent
- Exclusion Criteria:
- • Inability to follow the study protocol
- • Neuropsychiatric disease, developmental disorders
About I.R.C.C.S Ospedale Galeazzi Sant'ambrogio
The I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio is a leading clinical research institute and hospital in Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As a designated Institute of Hospitalization and Care of Scientific Relevance (I.R.C.C.S.), it focuses on translational research that bridges the gap between laboratory findings and clinical applications. The facility is equipped with state-of-the-art technology and a multidisciplinary team of experts, enabling it to conduct a wide range of clinical trials aimed at improving treatment outcomes across various medical fields. Its dedication to ethical practices and patient safety ensures that all research activities align with the highest international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Trial Officials
Matteo Briguglio
Principal Investigator
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported